Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Por um escritor misterioso
Descrição
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2 (CCR2) Antagonists
KR100837019B1 - 3-4-heteroarylcyclohexylaminocyclopentanecarboxamides as modulators of chemokine receptors - Google Patents
KR100837019B1 - 3-4-heteroarylcyclohexylaminocyclopentanecarboxamides as modulators of chemokine receptors - Google Patents
A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6+ T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation
Selective and Dual Targeting of CCR2 and CCR5 Receptors: A Current Overview
Sander G Mills's research works Merck & Co., Whitehouse Station (MSD) and other places
KR100837019B1 - 3-4-heteroarylcyclohexylaminocyclopentanecarboxamides as modulators of chemokine receptors - Google Patents
Full article: Future therapeutic treatment of COPD: Struggle between oxidants and cytokines
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. - Abstract - Europe PMC
Structural Analysis of Chemokine Receptor–Ligand Interactions
Malcolm MacCoss's research works Merck & Co., Whitehouse Station (MSD) and other places
Figures and data in Analysis of combinatorial chemokine receptor expression dynamics using multi-receptor reporter mice
Malcolm MacCoss's research works Merck & Co., Whitehouse Station (MSD) and other places
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2 (CCR2) Antagonists
Full article: Chemokine receptor antagonists: Part 1
